Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 28591 AL 28605

Development and concurrent validation of a retrogenetic instrument for the assessment of activities of daily living: the functional assessment scale of the Barcelona test

Torrente M, Pino M, Peña-Casanova J.

Neurologia (Engl Ed). 2025 Sep;40(7):651-660. doi: 10.1016/j.nrleng.2025.07.002. Epub 2025 Jul 17.

Validation of Spatial Orientation Screening questionnaire for use in memory clinic patients

Tangen GG, Engedal K, Persson K, Selbæk G, Dakhil S, McArdle R, Mjørud M, Røsvik J, Mengshoel AM, Knapskog AB.

J Alzheimers Dis. 2025 Feb;103(4):1013-1022. doi: 10.1177/13872877241308877. Epub 2025 Jan 15.

Turkish Version of the Video-Naming Test for Assessing Verb Anomia (DVAQ-30): Normative Data for the Adult Turkish Population and Validation Study in Mild Cognitive Impairment and Alzheimer's Disease

Tosun S, Karalı FS, Eskioğlu Eİ, Çınar N, Macoir J.

Int J Lang Commun Disord. 2025 Jul-Aug;60(4):e70068. doi: 10.1111/1460-6984.70068.

Neurovascular Decoupling Is Associated With Lobar Intracerebral Hemorrhages and White Matter Hyperintensities

van Dijk SE, Drenth N, Hafkemeijer A, Labadie G, Witjes-Ané MW, Baas F, Vreijling JP, Blauw GJ, Rombouts SARB, van der Grond J, van Rooden S.

J Am Heart Assoc. 2025 Feb 18;14(4):e038819. doi: 10.1161/JAHA.124.038819. Epub 2025 Feb 14.

The TDQ-60 Tr-a Picture-Naming Test to Assess Anomia in Turkish Adults and the Elderly: Normative Data and Validation Study in Alzheimer's Disease and Mild Cognitive Impairment

Karalı FS, Tosun S, Eskioğlu Eİ, Çınar N, Macoir J.

Arch Clin Neuropsychol. 2025 Apr 27;40(3):529-540. doi: 10.1093/arclin/acaf005.

Validating a brief performance-based measure of cognition and daily functioning in amnestic mild cognitive impairment and mild Alzheimer's disease

Schaefer SY, Reed AM, Duff K.

J Alzheimers Dis. 2025 Apr;104(3):835-840. doi: 10.1177/13872877251320379. Epub 2025 Mar 25.

A simulation study comparing anticholinergic drug use with polypharmacy for risk of death, dementia, and delirium in UK Biobank

Mur J, Stirland LE, Muniz-Terrera G, Leist AK.

J Gerontol A Biol Sci Med Sci. 2025 Nov 6;80(12):glaf232. doi: 10.1093/gerona/glaf232.

Family cohesion and conflict in the context of adult children and parents living with early-stage cognitive impairment

Wang Z, Wang K, Monin JK.

Aging Ment Health. 2025 Sep;29(9):1724-1730. doi: 10.1080/13607863.2025.2495282. Epub 2025 Apr 24.

Automatic brain segmentation in cognitive impairment: Validation of AI-based AQUA software in the Southeast Asian BIOCIS cohort

Vipin A, Binte Shaik Mohamed Salim R, Kim RE, Lee M, Kim HW, Rieu Z, Kandiah N.

Ann Acad Med Singap. 2025 Aug 22;54(8):467-475. doi: 10.47102/annals-acadmedsg.2024317.

Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment-A scoping review

Saini B, Kong SDX, Schrire ZM, Jacobson LH, Grunstein R, Naismith SL.

Pharmacol Rev. 2026 Jan;78(1):100094. doi: 10.1016/j.pharmr.2025.100094. Epub 2025 Oct 13.

Itel MMSE: a short phone screening test for cognitive decline. Italian Validation study by the SINdem Neuropsychology Working Group

Quaranta D, L'Abbate F, Pelosi A, Arighi A, Asoni G, Bagattini C, Bessi V, Bonanni L, Bortoletto M, Bruni AC, Cagnin A, Cappa SF, Giubilei F, Guarino M, Iavarone A, Isella V, Luca A, Monastero R, Pellegrini FF, Perini M, Piccoli T, Rainero I, Tedeschi G, Marra C, Caffarra P.

Neurol Sci. 2025 Apr;46(4):1617-1627. doi: 10.1007/s10072-024-07863-4. Epub 2024 Dec 4.

Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum

Padovani A, Caratozzolo S, Galli A, Crosani L, Zampini S, Cosseddu M, Turrone R, Zancanaro A, Gumina B, Vicini-Chilovi B, Benussi A, Vyshedskiy A, Pilotto A.

Neurol Sci. 2025 Feb;46(2):697-704. doi: 10.1007/s10072-024-07775-3. Epub 2024 Sep 24.

Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review

Zhao R, Bai W, Tian Z, Li X, Sun R, Wang Z, Yan X, Jia J.

J Alzheimers Dis. 2025 Sep;107(2):409-420. doi: 10.1177/13872877251361053. Epub 2025 Sep 1.

Conversion of subjective cognitive decline to MCI and dementia: a systematic review and meta-analysis of sex differences and risk factors

Tallman MD, Timblin H, Maynard T, Kelly BE, MacAulay RK.

J Clin Exp Neuropsychol. 2026 May;48(4):405-417. doi: 10.1080/13803395.2025.2609824. Epub 2025 Dec 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias